In a diabetic rat model, alterations in beta-adrenergic receptors and adenylate cyclase coupling emerge after 4 weeks, suggesting a mechanism for the development of diabetic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for time-dependent beta-adrenergic impairment in diabetic cardiomyopathy; leaves open translation to human disease.
Cardiomyopathy is a complication of human diabetes mellitus. The relationship of cardiac function to the beta-adrenergic receptor and catecholamine-stimulated adenylate cyclase activity was investigated in the streptozotocin-diabetic rat. beta-Adrenergic receptor number in cardiac membranes from diabetic rats was reduced. After 2 weeks of diabetes, the response of adenylate cyclase to isoproterenol stimulation was not altered. Cardiac contractile function assessed by the maximum rate of rise of left ventricular pressure (LV dP/dtmax) in an open-chest anesthetized rat was also unchanged from control at 2 weeks. However, after 4 weeks of diabetes, the sensitivity of adenylate cyclase to isoproterenol stimulation was depressed and abnormalities in cardiac contractility were noted, including a depressed response of LV dP/dtmax to graded isoproterenol infusion. These studies suggest that alterations in beta-adrenergic receptors and their coupling to adenylate cyclase may be important in the development of diabetic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Atkins et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: